Viral entry and NS1 as potential antiviral drug targets

Aravinda M. de Silva; Félix A. Rey; Paul R. Young; Rolf Hilgenfeld; Subhash G. Vasudevan

doi:10.1007/978-981-10-8727-1_8

Viral entry and NS1 as potential antiviral drug targets

Aravinda M. de Silva, Félix A. Rey, Paul R. Young, Rolf Hilgenfeld^*, Subhash G. Vasudevan

^*Korrespondierende/r Autor/-in für diese Arbeit

Institut für Biochemie

5 Zitate (Scopus)

Abstract

A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

Originalsprache	Englisch
Titel	Advances in Experimental Medicine and Biology
Seitenumfang	7
Band	1062
Erscheinungsort	Singapore
Herausgeber (Verlag)	Springer Singapore
Erscheinungsdatum	01.01.2018
Seiten	107-113
ISBN (Print)	978-981-10-8726-4
ISBN (elektronisch)	978-981-10-8727-1
DOIs	https://doi.org/10.1007/978-981-10-8727-1_8
Publikationsstatus	Veröffentlicht - 01.01.2018

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Dokumente

10.1007/978-981-10-8727-1_8

Weitere Links

Link to publication in Scopus

Zitieren

@inbook{110f67a0b8464e70a66e4f41c2fd928b,

title = "Viral entry and NS1 as potential antiviral drug targets",

abstract = "A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.",

author = "\{de Silva\}, \{Aravinda M.\} and Rey, \{F{\'e}lix A.\} and Young, \{Paul R.\} and Rolf Hilgenfeld and Vasudevan, \{Subhash G.\}",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/978-981-10-8727-1\_8",

language = "English",

isbn = "978-981-10-8726-4",

volume = "1062",

series = "Advances in Experimental Medicine and Biology",

publisher = "Springer Singapore",

pages = "107--113",

booktitle = "Advances in Experimental Medicine and Biology",

}

Viral entry and NS1 as potential antiviral drug targets. / de Silva, Aravinda M.; Rey, Félix A.; Young, Paul R. et al.
Advances in Experimental Medicine and Biology. Band 1062 Singapore: Springer Singapore, 2018. S. 107-113 (Advances in Experimental Medicine and Biology; Band 1062).

Publikation: Kapitel in Büchern/Berichten/Konferenzbänden › Kapitel › Begutachtung

TY - CHAP

T1 - Viral entry and NS1 as potential antiviral drug targets

AU - de Silva, Aravinda M.

AU - Rey, Félix A.

AU - Young, Paul R.

AU - Hilgenfeld, Rolf

AU - Vasudevan, Subhash G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

AB - A general discussion on viral entry and NS1 as potential drug targets was held at the Tofo Advanced Study Week (TASW) on Emerging Viral Diseases in September 2016. The opportunities and gaps for developing therapeutic countermeasures, to take advantage of the high-resolution cryo-electron microscopy structures of dengue and Zika viruses as well as the novel features of NS1 revealed by the 3D structures, were deliberated.

UR - https://www.scopus.com/pages/publications/85048015735

U2 - 10.1007/978-981-10-8727-1_8

DO - 10.1007/978-981-10-8727-1_8

M3 - Chapter

AN - SCOPUS:85048015735

SN - 978-981-10-8726-4

VL - 1062

T3 - Advances in Experimental Medicine and Biology

SP - 107

EP - 113

BT - Advances in Experimental Medicine and Biology

PB - Springer Singapore

CY - Singapore

ER -

Viral entry and NS1 as potential antiviral drug targets

Abstract

UN SDGs

Strategische Forschungsbereiche und Zentren

Dokumente

Weitere Links

Fingerprint

Zitieren